ArticleFrontiers in pharmacology2026

A comparative real-world analysis of finerenone and steroidal mineralocorticoid receptor antagonists in patients with chronic kidney disease.

Daniele Vetrano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.